Dr Reddy’s Sells North American Rights For Celecoxib Oral Solution

As Company Partners With BioDelivery Sciences For Elyxyb

US Canada
Dr Reddy’s sells US and Canadian rights to its 25mg/ml Elyxyb celecoxib oral solution • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business